PAPER
Multicomponent Synthesis of Tertiary Benzylamines
253
4-[3-(Trifluoromethyl)benzyl]morpholine (3a)15
Light-yellow oil; yield: 1.84 g (75%).
1H NMR: d = 7.53 (br s, 1 H), 7.49–7.31 (m, 3 H), 3.70–3.58 (m, 4
H), 3.47 (s, 2 H), 2.45–2.28 (m, 4 H).
1H NMR: d = 7.31–7.22 (m, 1 H), 7.14–7.09 (m, 1 H), 7.06 (d, J =
5.9 Hz, 1 H), 3.52 (s, 2 H), 2.39 (br s, 4 H), 1.67–1.52 (m, 4 H),
1.49–1.34 (m, 2 H).
13C NMR: d = 139.3, 128.8, 125.1, 122.7, 58.3, 54.4, 25.9, 24.3.
13C NMR: d = 138.9, 132.4 (d, J = 1.0 Hz), 130.6 (q, J = 32.1 Hz),
128.7, 124.2 (q, J = 272.3 Hz), 125.7 (q, J = 3.8 Hz), 124.1 (q, J =
3.8 Hz), 66.9, 62.8, 53.6.
19F NMR: d = –62.61.
MS: m/z (%) = 182 (37), 181 (14), 180 (44), 98 (15), 97 (80), 85 (6),
84 (100), 56 (9), 53 (6).
Anal. Calcd for C10H15NS: C, 66.25; H, 8.34; N, 7.73. Found: C,
65.91; H, 8.17; N, 7.68.
MS: m/z (%) = 246 (30), 245 (99), 244 (63), 215 (13), 214 (100),
200 (5), 186 (9), 172 (11), 160 (19), 159 (92), 141 (12), 110 (6), 109
(18), 100 (12), 86 (45).
2-[(Thiophen-2-yl)methyl]-1,2,3,4-tetrahydroisoquinoline
(3g)3c
Orange semi-solid oil; yield: 1.96 g (85%).
Ethyl 4-[(Diethylamino)methyl]benzoate (3b)
Orange oil; yield: 1.96 g (83%).
1H NMR: d = 7.99 (d, J = 8.5 Hz, 2 H), 7.42 (d, J = 8.5 Hz, 2 H),
4.37 (q, J = 7.1 Hz, 2 H), 3.61 (s, 2 H), 2.52 (q, J = 7.1 Hz, 4 H),
1.39 (t, J = 7.1 Hz, 3 H), 1.04 (t, J = 7.1 Hz, 6 H).
1H NMR: d = 7.35 (dd, J = 4.7, 1.6 Hz, 1 H), 7.29–7.17 (m, 3 H),
7.13–7.02 (m, 3 H), 4.00 (s, 2 H), 3.81 (s, 2 H), 3.02 (t, J = 5.9 Hz,
2 H), 2.89 (t, J = 5.9 Hz, 2 H).
13C NMR: d = 142.0, 134.8, 134.4, 128.8, 126.8, 126.6, 126.3,
126.1, 125.8, 125.2, 57.0, 55.9, 50.4, 29.3.
13C NMR: d = 166.7, 145.5, 129.4, 129.0, 128.6, 60.8, 57.4, 46.9,
14.3, 11.7.
MS: m/z (%) = 229 (8), 228 (27), 145 (18), 133 (9), 132 (100), 117
(9), 105 (6), 104 (8), 103 (5), 97 (47), 78 (6).
MS: m/z (%) = 235 (9), 221 (12), 220 (100), 164 (8), 163 (76), 135
(12), 107 (7).
References
Anal. Calcd for C14H21NO2: C, 71.46; H, 8.99; N, 5.95. Found: C,
71.15; H, 8.83; N, 5.67.
(1) (a) Kise, N.; Ozaki, H.; Terui, H.; Ohya, K.; Ueda, N.
Tetrahedron Lett. 2001, 42, 7637. (b) Cecchetto, A.;
Minisci, F.; Recupero, F.; Fontanab, F.; Pedullic, G. F.
Tetrahedron Lett. 2002, 43, 3605.
4-(4-Methoxybenzyl)morpholine (3c)8
Yellow oil; yield: 1.56 g (75%).
(2) (a) Miyazaki, Y.; Kato, Y.; Manabe, T.; Shimada, H.;
Mizuno, M.; Egusa, T.; Ohkouchi, M.; Shiromizu, I.;
Matsusue, T.; Yamamoto, I. Bioorg. Med. Chem. Lett. 2006,
16, 2986. (b) Castellano, S.; La Colla, P.; Musiu, C.;
Stefancich, G. Arch. Pharm. (Weinheim, Ger.) 2000, 333,
162. (c) Nussbaumer, P.; Dorfstaetter, G.; Grassberger, M.
A.; Leitner, I.; Meingassner, J. G.; Thirring, K.; Stuetz, A.
J. Med. Chem. 1993, 36, 2115. (d) Hagihara, K.; Nishiya,
Y.; Kurihara, A.; Kazui, M.; Farid, N. A.; Ikeda, T. Drug
Metab. Pharmacokinet. 2008, 23, 412. (e) Altomare, C.;
Summo, L.; Cellamare, S.; Varlamov, A. V.;
1H NMR: d = 7.15 (d, J = 8.2 Hz, 2 H), 6.78 (d, J = 8.2 Hz, 2 H),
3.72 (s, 3 H), 3.67–3.55 (m, 4 H), 3.36 (s, 2 H), 2.34 (br s, 4 H).
13C NMR: d = 158.8, 130.4, 129.7, 113.6, 67.0, 62.8, 55.2, 53.5.
MS: m/z (%) = 208 (7), 207 (51), 206 (17), 176 (19), 135 (5), 134
(10), 122 (20), 121 (100), 91 (10), 86 (33), 77 (11).
1-(4-Methoxybenzyl)-4-phenylpiperazine (3d)3b
Light-brown solid; yield: 1.57 g (55%); mp 105–107 °C.
1H NMR: d = 7.35–7.20 (m, 4 H), 7.00–6.81 (m, 5 H), 3.82 (s, 3 H),
3.55 (s, 2 H), 3.30–3.13 (s, 4 H) 2.71–2.55 (s, 4 H).
13C NMR: d = 158.8, 151.3, 130.5, 129.1, 119.7, 116.0, 113.7, 62.4,
55.3, 52.9, 49.1.
Voskressensky, L. G.; Borisova, T. N.; Carotti, A. Bioorg.
Med. Chem. Lett. 2000, 10, 581. (f) Gooding, O. W.; Beard,
C. C. Heterocycles 1991, 32, 1777.
(3) (a) Abdel-Magid, A. F.; Carson, K. G.; Harris, B. D.;
MS: m/z (%) = 283 (22), 282 (100), 281 (7), 254 (15), 176 (9), 175
(9), 162 (7), 161 (12), 150 (5), 149 (68), 148 (44), 134 (15), 133 (7),
132 (10), 121 (45), 118 (6), 106 (10), 104 (8), 91 (9), 77 (9), 56 (9).
Maryanoff, C. A. J. Org. Chem. 1996, 61, 3849.
(b) Apodaca, R.; Xiao, W. Org. Lett. 2001, 3, 1745.
(c) Kumpaty, H. J.; Bhattacharyya, S. Synthesis 2005, 2205.
(4) (a) Hazari, N.; Mountford, P. Acc. Chem. Res. 2005, 38,
839. (b) Hultzsch, K. C. Adv. Synth. Catal. 2005, 347, 367.
(c) Hultzsch, K. C. Org. Biomol. Chem. 2005, 3, 1819.
(d) Xu, L. W.; Xia, C. G. Eur. J. Org. Chem. 2005, 633.
(e) Hong, S.; Marks, T. J. Acc. Chem. Res. 2004, 37, 673.
(f) Beller, M.; Tillack, A.; Seayad, J. In Transition Metals
for Organic Synthesis, 2nd ed., Vol. 2; Beller, M.; Bolm, C.,
Eds.; VCH: Weinheim, 2004, 403–414. (g) Nobis, M.;
Drieben-Hölscher, B. Angew. Chem. Int. Ed. 2001, 40,
3983. (h) Ricci, A. In Modern Amination Methods; Wiley-
VCH: Weinheim, 2000. (i) Müller, T.; Beller, M. Chem.
Rev. 1998, 98, 675.
1-[(6-Methoxynaphthalen-2-yl)methyl]piperidine (3e)
Light-brown solid; yield: 1.68 g (66%); mp 64–66 °C.
1H NMR: d = 7.69–7.54 (m, 3 H), 7.39 (d, J = 8.4 Hz, 1 H), 7.09–
7.01 (m, 2 H), 3.84 (s, 3 H), 3.55 (s, 2 H), 2.36 (br s, 4 H), 1.60–1.47
(m, 4 H), 1.42–1.29 (m, 2 H).
13C NMR: d = 157.5, 133.8, 129.2, 128.7, 128.3, 127.8, 126.6,
118.7, 105.6, 63.8, 55.3, 54.5, 25.8, 24.3.
MS: m/z (%) = 256 (6), 255 (28), 254 (22), 173 (9), 172 (77), 171
(100), 157 (12), 156(8), 129 (11), 128 (34), 84 (51).
Anal. Calcd for C17H21NO: C, 79.96; H, 8.29; N, 5.49. Found: C,
79.78; H, 8.31; N, 5.39.
(5) (a) The Chemistry of the Cyano Group; Rappoport, Z., Ed.;
Interscience: London, 1970. (b) Houben-Weyl, 4th ed., Vol.
E5; Grundmann, C., Ed.; Thieme: Stuttgart, 1985, 1313–
1441.
1-[(Thiophen-3-yl)methyl]piperidine (3f)
Yellow oil; yield: 1.31 g (72%).
Synthesis 2010, No. 2, 249–254 © Thieme Stuttgart · New York